SECURITIES AND EXCHANGE COMMISSION
                        ----------------------------------
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004

                            Commission File #2-89616

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

             (Exact name of registrant as specified in its charter)

                                     MONTANA

         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

               11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816
               (Address of principal executive offices)(Zip Code)

                                  225-292-5139
                (Registrant's telephone no., including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.
Yes  [X]  No  [_]

The  number  of shares outstanding of the Company's common stock as of September
30,  2004  is  shown  below:

Title  of  Class  Number of Shares Outstanding Common Stock, par value $.001 per
share  44,544,223.

Documents  Incorporated  by  Reference:  None


<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB


                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1 - Financial Information

Item 2 - Management's Discussion and Analysis of Financial Condition Operations

Item 3 - Controls and Procedures


PART II - OTHER INFORMATION

Item 2 - Changes in Securities and Use of Proceeds

Item 6 - Exhibits and Reports on Form 8-K

SIGNATURES


                                            2
<PAGE>
                         PART I - FINANCIAL INFORMATION

ITEM  1.  CONSOLIDATED  FINANCIAL  STATEMENTS
The  financial  statements  of  the company are set forth beginning on page F-1.

                         PART I - FINANCIAL INFORMATION
                         ------------------------------

ITEM  1.  FINANCIAL  STATEMENTS

AS  USED  HEREIN,  THE  TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC.  UNLESS  OTHERWISE  INDICATED.  CONSOLIDATED  UNAUDITED  INTERIM  FINANCIAL
STATEMENTS  INCLUDING  A  BALANCE  SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
SEPTEMBER 30, 2003, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY  THIS  REFERENCE.

                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]


                                        3
<PAGE>
<TABLE>
<CAPTION>
                                 CONSOLIDATED MINERALS MANAGEMENT, INC.
                                        (A MONTANA CORPORATION)
                                       CONSOLIDATED BALANCE SHEET
                                              (UNAUDITED)

                                                 ASSETS
                                                 ------

Current Assets                                                 September 30, 2004    December 31, 2003
--------------                                                --------------------  -------------------
<S>                                                           <C>                   <C>
Cash                                                          $               403   $           13,659
                                                              --------------------  -------------------

Total Current Assets                                                          403               13,659
                                                              --------------------  -------------------

Other Assets
------------
Oil & Gas Properties                                          $            60,000               60,000
Investment in Intercontinental Fuels LLC                                1,320,000            1,320,000
Note Receivable                                                         2,786,000            2,786,000
                                                              --------------------  -------------------
     Total Other Assets                                                 4,166,000            4,166,000
                                                              --------------------  -------------------

          Total Assets                                        $         4,166,403   $        4,179,659
                                                              ====================  ===================


                      LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                      ----------------------------------------------

Current Liabilities
-------------------


Notes Payable-Current Portion                                 $                     $           80,493
Accounts Payable                                                                               109,132
Accrued Expenses                                                          171,000              339,157
Convertible Debentures                                                       0                 465,000
Note Payable - Dr. Zehr                                                   150,000              150,000
Debentures Payable                                                        350,000              350,000
                                                              --------------------  -------------------

     Total Current Liabilities                                            671,000            1,493,782

Debenture Payable Dr. Zehr                                              2,000,000            2,000,000
Note Payable Dr. Zehr                                                     600,000              600,000
                                                              --------------------  -------------------
     Total Long-Term Liabilities                                        2,600,000            2,600,000
                                                              --------------------  -------------------

     Total Liabilities                                        $         3,271,000   $        4,093,782
                                                              --------------------  -------------------
Stockholders' Equity
--------------------
     Preferred Stock
        20,000,000 authorized shares, par value $.001
        no shares issued and outstanding
     Common Stock                                             $            44,544               44,173
     $0.001 par value, 50,000,000 shares authorized
     44,544,223 shares issued and outstanding as of
     September 30, 2004 and 44,264,285 issued and
     Outstanding as of December 31, 2003.

     Additional Paid-in-Capital                                         4,332,172            4,047,605
     Retained Earnings (Deficit)                                       (3,481,313)          (4,005,901)
                                                              --------------------  -------------------

        Total Stockholders' Equity (Deficit)                              895,403               85,877
                                                              --------------------  -------------------

        Total Liabilities and Stockholders' Equity (Deficit)  $         4,166,403   $        4,179,659
                                                              ====================  ===================
</TABLE>


                                        4
<PAGE>
<TABLE>
<CAPTION>
                            CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                   (A MONTANA CORPORATION)
                            CONSOLIDATED STATEMENT OF OPERATIONS
                                         (UNAUDITED)

                            NINE MONTHS ENDED SEPTEMBER 30, 2004
                            ------------------------------------

                                   THREE MONTHS ENDED SEPT 30,  NINE MONTHS ENDED SEPT 30,
                                    ------------------------  ------------------------------
                                       2004         2003          2004            2003
                                    -----------  -----------  ------------  ----------------
<S>                                 <C>          <C>         <C>            <C>
Revenues                            $    0       $  60,000   $      0       $    75,042
--------

Operating Expenses
    Personnel Costs                    24,000      147,000        67,000         193,500
    Consulting                        312,938       10,700       398,622          18,650
    Legal and Professional                0         11,260         1,578          35,575
    Other Expenses                        0         31,460        17,996          84,879
                                    -----------  -----------  ------------  ----------------

    Total Operating Expenses        $ 336,938     $ 200,420   $  485,196 $       332,604

Income (Loss) from Operations        (336,938)     (140,420)    (485,196)       (257,562)

Other Income (Expenses)             1,030,126                  1,030,126
      Interest Expense                    0                       20,342        ( 11,625)

                                    -----------  -----------  ------------  ----------------

Income (Loss) before Income Taxes  $  693,188    $ (140,420)   $ 524,588        (269,187)

Income Tax Expense                                    0                              0
                                    -----------  -----------  ------------  ----------------

Net Income (Loss)                  $  693,188    $ (140,420)   $ 524,588    $   (269,187)
                                    ===========  ===========  ============  ================

Net Income (Loss) per Share         $    .0156     $  (.003)  $     .0118   $     (.0063)
                                    ===========  ===========  ============  ================
</TABLE>


                                        5
<PAGE>
<TABLE>
<CAPTION>
                           CONSOLIDATED MEDICAL MANAGEMENT, INC
                                 (A MONTANA CORPORATION)
                              CONSOLIDATED STATEMENT OF CASH
                                       (UNAUDITED)
                             NINE MONTHS ENDED SEPTEMBER 30
                             -------------------------------

Cash Flows from Operating Activities:                             2004          2003
-------------------------------------                          -----------  -------------
<S>                                                            <C>          <C>
     Net Income (Loss)                                         $ 693,188    $   (140,420)
     Adjustments to Reconcile Net Income (Loss) to
        Net Cash Provided by Operating Activities:
              Depreciation and Amortization
              (Increase) Decrease in Investment                                 (750,000)
              (Increase) Decrease in Receivables                                    0
              (Decrease) Increase in Accounts Payable           (161,131)         (6,685)
              (Increase) Decrease in Interest Payable                               0
              (Increase) Decrease in Accrued Expenses           (346,994)           0
                                                               -----------  -------------

            Net Cash Provided (Used) by Operating Activities   $ 185,063   $    (897,105)
                                                               -----------  -------------

Cash Flows from Investing Activities:
-------------------------------------

        Oil & Gas Properties                                                      60,000
                                                               -----------  -------------

            Net Cash Provided (Used) by Investing Activities   $            $     60,000
                                                               -----------  -------------

Cash Flows from Financing Activities:
-------------------------------------
     Increase (decrease) in Long-Term Debt                      (465,000)        750,000
     Increase in Short-Term Debt                                                   0
     Increase in Paid in capital                                 279,666          88,000
     Common Stock                                                    271           7,000
                                                               -----------  -------------

            Net Cash Provided (Used) by Financing Activities   $ (185,063)  $    845,000
                                                               -----------  -------------

Net Increase (Decrease) in Cash                                      0             7,895

Cash, Beginning of period                                             403          4,901
                                                               -----------  -------------

Cash, End of period                                                   403    $    12,796
                                                               ===========  =============
</TABLE>


                                        6
<PAGE>
NOTE 1 - BASIS OF PRESENTATION
------------------------------

GENERAL
-------

The unaudited interim financial statements of the Company as of September 30,
2004 and for the three months and nine months ended September 30, 2004, included
herein have been prepared in accordance with the instructions for Form 10QSB
under the Securities Exchange Act of 1934, as amended, and Article 10 of
Regulation S-X under the Securities Act of 1933, as amended. The December 31,
2003 Consolidated Balance Sheet was derived from audited financial statements,
but does not include all disclosures required by generally accepted accounting
principles. Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating to interim consolidated financial statements.

In the opinion of management, the accompanying consolidated unaudited interim
financial statements reflect all adjustments, consisting only of normal
recurring adjustments, necessary to present fairly the financial position of the
Company at September 30, 2004, and the results of their operations for the three
and nine months ended September 30, 2004 and September 30, 2003, and their cash
flows for the three and nine months ended September 30, 2004 and September 30,
2003.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2003 and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission.

                                  ORGANIZATION

The Company was incorporated under the laws of the State of Montana on August
13, 1981 under the name Golden Maple Mining and Leaching Company, Inc. On May
23, 1998, we changed our name to Consolidated Medical Management, Inc. In
August, 2001, the Company decided to refocus on the oil and gas industry and are
currently doing business as Consolidated Minerals Management, Inc. CMMI moved
its office in July 2003 to Baton Rouge, LA.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
---------------------------------------------------

ACCOUNTING  METHOD
------------------

Accounting policies of the Company conform to the generally accepted accounting
principles and reflect practices appropriate to the industry in which it
operates. The significant policies are summarized below.


PROPERTY, EQUIPMENT AND DEPRECIATION

Expenditures  for  property,  plant and equipment are recorded at cost. Renewals
and  improvements,  which  extend  the  economic  life  of  such  assets,  are
capitalized.  Expenditures  for  maintenance,  repairs  and  other  renewals are
charged  to  expense.  For  major  dispositions,  the  cost  and  accumulated
depreciation  are  removed from the accounts and any gain or loss in included in
the  results  of  operations.

CASH FLOWS AND CONCENTRATION OF CREDIT RISK
-------------------------------------------

Cash consists principally of demand deposits at commercial banks. These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance Corporation up to $100,000. At December 31, 2003 and September 30,
2004, the Company's deposits did not exceed the insured limits.

EARNINGS PER COMMON SHARE
-------------------------

The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share," which simplifies the computation of earnings per share requiring the
restatement of all prior periods.

Basic earnings per share are computed on the basis of the weighted average
number of common shares outstanding during each year.

Diluted earnings per share are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding. Dilutive securities
having an anti-dilutive effect on diluted earnings per share are excluded from
the calculation. The Company does not have any dilutive securities as of
September 30, 2004.


                                        7
<PAGE>
COVERTIBLE DEBENTURES AND NOTES PAYABLE
---------------------------------------

The Company issued a $2,000,000 convertible debenture on April 15, 2003 which is
unsecured and includes interest at 5% per annum. The debenture matures on April
15, 2006. It is convertible at the option of the holder after April 15, 2004
into $2,000,000 of Common stock at a cost of 70% of the average bid price for
the stock for the immediate twenty days before the exercise.

The Company issued a $350,000 debenture on April 15, 2003 which is unsecured and
includes interest at 5% per annum. The debenture matured on October 15, 2003.

The Company issued a $600,000 note payable on July 1, 2003 which is unsecured
and includes interest at 5% per annum. The note is payable upon permanent
financing of Intercontinental Fuels, LLC (IFL) plant facility. CMMI owns 60% of
the membership interest in IFL.

The Company issued a $150,000 note payable on July 5, 2003 which is unsecured
and includes interest at 4% per annum. Interest is payable monthly and was due
January 6, 2004.

NOTE 5 - COMMON AND PREFERRED STOCK
-----------------------------------

COMMON  STOCK
-------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of December 31, 2003 and September 30, 2004, the Company had
44,544,223 and 44,264,285 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock. There
are 20,000,000 shares authorized with a par value of $0.001. The shares are
non-voting and non-redeemable by the Company. The Company further designated two
series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares. As of
September 30, 2004 and December 31, 2003 there are no shares issued and
outstanding.

DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such respective dividend payment date. In no event
shall the holders of either series receive dividends of more than one percent
(1%) in any fiscal year. Each share of both series shall rank on parity with
each other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" or $12.50 Preferred Stock. The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock. The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.


                                        8
<PAGE>
COMMITMENT AND CONTINGENCIES

The company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern.

ITEM 2.  MANAGEMENT  DISCUSSION  AND  ANAYLSIS  OF FINACIAL CONDITION OR PLAN OF
         OPERATIONS.

The following discussion should be read in conjunction with our unaudited
consolidated interim financial statements and related notes thereto included in
this quarterly report and in our audited consolidated financial statements and
Management's Discussion and Analysis of Financial Condition and Results of
Operations (MD&A") contained in our Form 10-KSB for the year ended December 31,
2003. Certain statements in the following MD&A are forward looking statements.
Words such as "expects", "anticipates", "estimates" and similar expressions are
intended to identify forward-looking statements. Such statements are subject to
risks and uncertainties that could cause actual results to differ materially
from those projected.

GENERAL

Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws
of the State of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc. In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc.

RESULTS OF OPERATIONS

For the quarter ended September 30, 2004 the Company had no revenues from
operations. The Company is continually trying to capitalize its investment in
Intercontinental Fuels, LLC so that when that facility is on line, operational
revenue will begin. The Company believes that its efforts to accomplish this
will come to fruition in either the fourth quarter of 2004 or the first quarter
of 2005. The Company continues to incur and accrue expenses for consultants that
are necessary for it to achieve the operational status it is striving for.


                                        9
<PAGE>
COMPARISON OF QUARTER ENDED SEPTEMBER 30, 2004 TO THE QUARTER ENDED SEPTEMBER
30, 2003

For the quarter ended September 30, 2004, our net income was $693,188 as
compared to a net loss of $140,407 for the quarter ended September 30, 2003.
CMMI decided to recognize as income in the third quarter, outstanding
liabilities that were incurred over five years ago. It has been determined that
the statutory period for a debtor to take legal action to recover these unpaid
balances has passed. Therefore, the appropriate action is to take the amounts
that were once recorded as expenses and recognize them as income from discharge
of indebtedness. Were it not for this adjustment, the Company would have had a
loss in the third quarter in the amount of $ 336,938 as the result of accruing
personnel costs and consultant's costs.


LIQUIDITY AND CAPITAL RESOURCES

Currently, the liabilities shown on the balance sheet are current trade
payables, accrued expenses and debentures payable related to financing the
acquisition of the fuel terminal facility in Houston, TX. All of the payables
and debentures related to the time period that CMMI was in the home health
business have been written off and included in the third quarter as other, non
recurring income.

The Company's current financial situation raise substantial doubt as to the
Company's ability to continue as a going concern. The Company will need to raise
additional funds via debt or equity financing to continue operations. There can
be no assurance that additional capital will be available when needed or on
terms acceptable to the Company.

The market price of the Company's common stock has fluctuated significantly
since in began to be publicly traded in 1998 and may continue to be highly
volatile. Factors such as the ability of the Company to achieve development
goals, ability of the Company to profitably complete energy projects, the
ability of the Company to raise additional funds, general market conditions and
other factors affecting the Company's business that are beyond the Company's
control may cause significant fluctuations in the market price of the Company's
common stock. The market prices of the stock of many energy companies have
fluctuated substantially, often unrelated to the operating or research and
development performance of the specific companies. Such market fluctuations
could adversely affect the market price for the Company's common stock.


                                       10
<PAGE>
                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

EXHIBIT INDEX


EXHIBIT 31     Certifications
EXHIBIT 32.1   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 302 of the Sarbanes Oxley
               Act of 2002, with respect to the registrant's quarterly report on
               Form 10qsb for the quarter ended September 30, 2004
EXHIBIT 32.2   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 906 of the Sarbanes Oxley
               Act of 2002, with respsect to the registrants quarterly report on
               Form 10QSB for the quarter ended September 30, 2004.


                                   SIGNATURES

Pursuant  to  the requirements of section 13 or 15(d) of the Securities Exchange
Act  of  1934,  the undersigned has duly caused this Form 10-QSB to be signed on
its  behalf by the undersigned, there unto duly authorized, in the City of Baton
Rouge,  LA,  on  November  11,  2003.

CONSOLIDATED MEDICAL MANAGEMENT, INC.


               By:  /s/ Timothy G. Byrd, Sr.

                    Timothy G. Byrd, Sr.
                    Chief Executive Officer, Acting Chief Accounting Officer, an



                                  EXHIBIT INDEX
                                  -------------

EXHIBIT 31     Certifications

EXHIBIT 32.1   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 302 of the Sarbanes Oxley
               Act of 2002, with respect to the registrant's quarterly report on
               Form 10qsb for the quarter ended September 30, 2004

EXHIBIT 32.2   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 906 of the Sarbanes Oxley
               Act of 2002, with respsect to the registrants quarterly report on
               Form 10QSB for the quarter ended September 30, 2004.


<PAGE>